Augmedix Stock Price To Sales
Augmedix fundamentals help investors to digest information that contributes to Augmedix's financial success or failures. It also enables traders to predict the movement of Augmedix Stock. The fundamental analysis module provides a way to measure Augmedix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Augmedix stock.
Augmedix |
Augmedix Company Price To Sales Analysis
Augmedix's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Augmedix Price To Sales | 2.25 X |
Most of Augmedix's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Augmedix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Augmedix has a Price To Sales of 2.2518 times. This is 89.48% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 80.28% higher than that of the company.
Augmedix Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Augmedix's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Augmedix could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics of similar companies.Augmedix is currently under evaluation in price to sales category among its peers.
Augmedix Fundamentals
Return On Equity | -3.3 | |||
Return On Asset | -0.31 | |||
Profit Margin | (0.46) % | |||
Operating Margin | (0.64) % | |||
Current Valuation | 113.21 M | |||
Shares Outstanding | 49.43 M | |||
Shares Owned By Insiders | 1.50 % | |||
Shares Owned By Institutions | 84.78 % | |||
Number Of Shares Shorted | 1.07 M | |||
Price To Book | 11.09 X | |||
Price To Sales | 2.25 X | |||
Revenue | 44.85 M | |||
Gross Profit | 13.95 M | |||
EBITDA | (17.68 M) | |||
Net Income | (19.17 M) | |||
Cash And Equivalents | 29.99 M | |||
Cash Per Share | 0.80 X | |||
Total Debt | 25.85 M | |||
Debt To Equity | 1.54 % | |||
Current Ratio | 2.89 X | |||
Book Value Per Share | 0.21 X | |||
Cash Flow From Operations | (15.44 M) | |||
Short Ratio | 5.73 X | |||
Earnings Per Share | (0.47) X | |||
Target Price | 2.92 | |||
Number Of Employees | 1.43 K | |||
Beta | -0.19 | |||
Market Capitalization | 116.16 M | |||
Total Asset | 66.71 M | |||
Retained Earnings | (144.96 M) | |||
Working Capital | 33.2 M | |||
Net Asset | 66.71 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |